WO1994005332A3 - Glycolation de macromolecules glycosylees - Google Patents
Glycolation de macromolecules glycosylees Download PDFInfo
- Publication number
- WO1994005332A3 WO1994005332A3 PCT/US1993/008196 US9308196W WO9405332A3 WO 1994005332 A3 WO1994005332 A3 WO 1994005332A3 US 9308196 W US9308196 W US 9308196W WO 9405332 A3 WO9405332 A3 WO 9405332A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- macromolecule
- macromolecules
- polyalkylene glycol
- glycosylated
- diamino compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
L'invention concerne un procédé de couplage de glycols à des macromolécules par glycosylations sur ces dernières et non par des groupes amino ou carboxyle sur le squelette de celles-ci. On produit ainsi des macromolécules à réponse immunogène réduite et à activité maintenue. Ledit procédé de glycosylation d'une macromolécule glycosylée consiste à activer un glycol de polyalkylène; à faire réagir le glycol de polyalkylène activé avec un composé diamino, le glycol de polyalkylène activé étant couplé au composé diamino par un de ses groupes amino; à oxyder la macromolécule afin d'activer au moins un groupe glycosyl qu'elle contient; et à faire réagir le glycol de polyalkylène couplé au composé diamino avec le groupe glycosyl oxydé dans la macromolécule. On obtient ainsi une macromolécule glycosylée glycolée dans laquelle le glycol est lié à la macromolécule par ses glycosylations.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU50981/93A AU5098193A (en) | 1992-09-01 | 1993-09-01 | Glycolation of glycosylated macromolecules |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93777992A | 1992-09-01 | 1992-09-01 | |
| US07/937,779 | 1992-09-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO1994005332A2 WO1994005332A2 (fr) | 1994-03-17 |
| WO1994005332A3 true WO1994005332A3 (fr) | 1994-04-14 |
Family
ID=25470393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1993/008196 Ceased WO1994005332A2 (fr) | 1992-09-01 | 1993-09-01 | Glycolation de macromolecules glycosylees |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU5098193A (fr) |
| WO (1) | WO1994005332A2 (fr) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7538092B2 (en) | 2002-10-08 | 2009-05-26 | Fresenius Kabi Deutschland Gmbh | Pharmaceutically active oligosaccharide conjugates |
| US8840879B2 (en) | 2004-03-11 | 2014-09-23 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
| US8916518B2 (en) | 2002-03-06 | 2014-12-23 | Fresenius Kabi Deutschland Gmbh | Coupling proteins to a modified polysaccharide |
| US8969532B2 (en) | 2006-10-03 | 2015-03-03 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
| US9029331B2 (en) | 2005-01-10 | 2015-05-12 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor |
| US9187546B2 (en) | 2005-04-08 | 2015-11-17 | Novo Nordisk A/S | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
| US9187532B2 (en) | 2006-07-21 | 2015-11-17 | Novo Nordisk A/S | Glycosylation of peptides via O-linked glycosylation sequences |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050019325A1 (en) | 1996-01-08 | 2005-01-27 | Carter Paul J. | WSX receptor agonist antibodies |
| AU721129B2 (en) * | 1996-01-08 | 2000-06-22 | Genentech Inc. | WSX receptor and ligands |
| US7074397B1 (en) | 1996-01-08 | 2006-07-11 | Genentech, Inc. | Method for enhancing proliferation or differentiation of a cell using ob protein |
| US6541604B1 (en) | 1996-01-08 | 2003-04-01 | Genentech, Inc. | Leptin receptor having a WSX motif |
| US7063958B1 (en) * | 1996-01-16 | 2006-06-20 | The Rockefeller University | Nucleic acids db, the receptor for leptin |
| DK1007082T3 (da) | 1997-01-15 | 2007-02-19 | Phoenix Pharmacologics Inc | Modificeret tumor nekrose faktor |
| US6183738B1 (en) | 1997-05-12 | 2001-02-06 | Phoenix Pharamacologics, Inc. | Modified arginine deiminase |
| AU766190B2 (en) | 1998-10-16 | 2003-10-09 | Biogen Idec Ma Inc. | Interferon-beta fusion proteins and uses |
| DK1656952T3 (da) | 1998-10-16 | 2014-01-20 | Biogen Idec Inc | Polyalkylenglycolkonjugater af interferon beta-1A og anvendelser deraf |
| US7226903B2 (en) | 2001-10-10 | 2007-06-05 | Neose Technologies, Inc. | Interferon beta: remodeling and glycoconjugation of interferon beta |
| US7265084B2 (en) | 2001-10-10 | 2007-09-04 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| US7157277B2 (en) | 2001-11-28 | 2007-01-02 | Neose Technologies, Inc. | Factor VIII remodeling and glycoconjugation of Factor VIII |
| US7297511B2 (en) | 2001-10-10 | 2007-11-20 | Neose Technologies, Inc. | Interferon alpha: remodeling and glycoconjugation of interferon alpha |
| US7214660B2 (en) * | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| US7696163B2 (en) | 2001-10-10 | 2010-04-13 | Novo Nordisk A/S | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| US7439043B2 (en) | 2001-10-10 | 2008-10-21 | Neose Technologies, Inc. | Galactosyl nucleotide sugars |
| EP2292273A3 (fr) | 2001-10-10 | 2011-11-23 | BioGeneriX AG | Remodelage et Glycoconjugaison de Peptides |
| US7265085B2 (en) | 2001-10-10 | 2007-09-04 | Neose Technologies, Inc. | Glycoconjugation methods and proteins/peptides produced by the methods |
| US7473680B2 (en) | 2001-11-28 | 2009-01-06 | Neose Technologies, Inc. | Remodeling and glycoconjugation of peptides |
| MXPA05002594A (es) * | 2002-09-11 | 2005-05-27 | Fresenius Kabi Gmbh | Derivados de polipeptidos con hidroxialquilalmidon, especialmente derivados de eritropoyetina con hidroxialquilalmidon. |
| ES2477118T3 (es) | 2002-11-18 | 2014-07-15 | Polaris Group | Método para inhibir la replicaci�n viral in vivo |
| AU2004221824B2 (en) | 2003-03-14 | 2009-08-27 | Ratiopharm Gmbh | Branched water-soluble polymers and their conjugates |
| WO2004091499A2 (fr) | 2003-04-09 | 2004-10-28 | Neose Technologies, Inc. | Formation intracellulaire de conjugues de peptides |
| US8791070B2 (en) | 2003-04-09 | 2014-07-29 | Novo Nordisk A/S | Glycopegylated factor IX |
| CA2522345A1 (fr) | 2003-04-09 | 2004-11-18 | Neose Technologies, Inc. | Methode de glycopegylation et proteines/peptides produits au moyen de ces methodes |
| WO2005012484A2 (fr) | 2003-07-25 | 2005-02-10 | Neose Technologies, Inc. | Conjugues anticorps-toxines |
| NZ547168A (en) | 2003-11-24 | 2010-05-28 | Biogenerix Ag | Glycopegylated erythropoietin |
| US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
| EP1694351A2 (fr) * | 2003-12-03 | 2006-08-30 | Neose Technologies, Inc. | Hormone stimulant le follicule humain glycopegyle |
| NZ548123A (en) | 2004-01-08 | 2010-05-28 | Novo Nordisk As | O-linked glycosylation of peptides |
| CA2565414A1 (fr) | 2004-05-04 | 2005-11-24 | Novo Nordisk Health Care Ag | Glycoformes de polypeptides o-liees et leur procede de fabrication |
| WO2006010143A2 (fr) | 2004-07-13 | 2006-01-26 | Neose Technologies, Inc. | Remodelage de peg ramifie et glycosylation de peptide-1 semblable a glucagon [glp-1] |
| WO2006031811A2 (fr) | 2004-09-10 | 2006-03-23 | Neose Technologies, Inc. | Interferon alpha glycopegyle |
| EP1814573B1 (fr) | 2004-10-29 | 2016-03-09 | ratiopharm GmbH | Remodelage et glycopegylation du facteur de croissance des fibroblastes (fgf) |
| US20080255026A1 (en) | 2005-05-25 | 2008-10-16 | Glycopegylated Factor 1X | Glycopegylated Factor Ix |
| US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
| US20090048440A1 (en) | 2005-11-03 | 2009-02-19 | Neose Technologies, Inc. | Nucleotide Sugar Purification Using Membranes |
| US7985839B2 (en) | 2006-03-31 | 2011-07-26 | Baxter International Inc. | Factor VIII polymer conjugates |
| WO2007126808A1 (fr) | 2006-03-31 | 2007-11-08 | Baxter International Inc | Facteur viii pégylé |
| US7982010B2 (en) | 2006-03-31 | 2011-07-19 | Baxter International Inc. | Factor VIII polymer conjugates |
| US7645860B2 (en) | 2006-03-31 | 2010-01-12 | Baxter Healthcare S.A. | Factor VIII polymer conjugates |
| DK2101821T3 (da) | 2006-12-15 | 2014-10-06 | Baxter Healthcare Sa | Faktor VIIA-(poly)sialinsyre-konjugat med forlænget halveringstid in vivo |
| EP2144923B1 (fr) | 2007-04-03 | 2013-02-13 | BioGeneriX AG | Méthodes de traitement à l'aide d'un facteur g-csf glycopégylé |
| WO2008154639A2 (fr) | 2007-06-12 | 2008-12-18 | Neose Technologies, Inc. | Procédé amélioré pour la production de sucres de nucléotide |
| US8546328B2 (en) | 2007-08-27 | 2013-10-01 | Biogenerix Ag | Liquid formulation of G-CSF conjugate |
| WO2009094172A2 (fr) | 2008-01-22 | 2009-07-30 | Araim Pharmaceuticals, Inc. | Peptides protecteurs de tissu et analogues peptidiques pour la prévention et le traitement de maladies et de troubles associés à un endommagement tissulaire |
| US20130189239A1 (en) | 2008-02-27 | 2013-07-25 | Novo Nordisk A/S | Conjugated Factor VIII Molecules |
| EP2672260A1 (fr) | 2008-05-13 | 2013-12-11 | Advanced Liquid Logic, Inc. | Procédés, systèmes et dispositifs associés à un positionneur de gouttelettes |
| US8809501B2 (en) | 2009-07-27 | 2014-08-19 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| BR112012001814A8 (pt) | 2009-07-27 | 2018-02-06 | Baxalta GmbH | Conjugados de proteína de coagulação sanguínea |
| US8642737B2 (en) | 2010-07-26 | 2014-02-04 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| RU2744370C2 (ru) | 2009-07-27 | 2021-03-05 | Баксалта Инкорпорейтед | Конъюгаты белков свертывания крови |
| EP3081233B1 (fr) | 2009-07-27 | 2020-12-23 | Baxalta GmbH | Glycopolysialylation de protéines autres que des protéines de coagulation sanguine |
| ES2800983T3 (es) | 2010-12-22 | 2021-01-07 | Baxalta GmbH | Materiales y métodos para conjugar un derivado de ácido graso soluble en agua con una proteína |
| HK1200695A1 (en) | 2012-04-16 | 2015-08-14 | Cantab Biopharmaceuticals Patents Limited | Optimised subcutaneous therapeutic agents |
| JP2019523633A (ja) | 2016-04-29 | 2019-08-29 | アライム ファーマシューティカルズ,インコーポレーテッド | 組織の損傷に関連した疾患及び障害を予防及び治療する組織保護ペプチド |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989006546A1 (fr) * | 1988-01-20 | 1989-07-27 | Cetus Corporation | Conjugaison d'un polymere avec la proteine csf-1 |
| EP0442724A2 (fr) * | 1990-02-13 | 1991-08-21 | Kirin-Amgen, Inc. | IL-6 humaine modifiée |
| WO1993012220A1 (fr) * | 1991-12-12 | 1993-06-24 | Berlex Laboratories, Inc. | ANTICORPS DE RECOMBINAISON ET CHIMERIQUES CONTRE c-erbB-2 |
-
1993
- 1993-09-01 WO PCT/US1993/008196 patent/WO1994005332A2/fr not_active Ceased
- 1993-09-01 AU AU50981/93A patent/AU5098193A/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989006546A1 (fr) * | 1988-01-20 | 1989-07-27 | Cetus Corporation | Conjugaison d'un polymere avec la proteine csf-1 |
| EP0442724A2 (fr) * | 1990-02-13 | 1991-08-21 | Kirin-Amgen, Inc. | IL-6 humaine modifiée |
| WO1993012220A1 (fr) * | 1991-12-12 | 1993-06-24 | Berlex Laboratories, Inc. | ANTICORPS DE RECOMBINAISON ET CHIMERIQUES CONTRE c-erbB-2 |
Non-Patent Citations (2)
| Title |
|---|
| CHEMICAL ABSTRACTS, vol. 103, no. 11, 16 September 1985, Columbus, Ohio, US; abstract no. 84021 * |
| VERONESE F. ET AL.: "SURFACE MOFIFICATION OF PROTEINS. ACTIVATION OF MONOMETHOXY-POLYETHYLENE GLYCOLS BY PHENYLCHLOROFORMATES AND MODIFICATION OF RIBONUCLEASE AND SUPEROXIDE DISMUTASE.", APPL. BIOCHEM. BIOTECHNOL., vol. 11, no. 2, 1985, pages 141 - 152 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8916518B2 (en) | 2002-03-06 | 2014-12-23 | Fresenius Kabi Deutschland Gmbh | Coupling proteins to a modified polysaccharide |
| US7538092B2 (en) | 2002-10-08 | 2009-05-26 | Fresenius Kabi Deutschland Gmbh | Pharmaceutically active oligosaccharide conjugates |
| US8840879B2 (en) | 2004-03-11 | 2014-09-23 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
| US9029331B2 (en) | 2005-01-10 | 2015-05-12 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor |
| US9187546B2 (en) | 2005-04-08 | 2015-11-17 | Novo Nordisk A/S | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
| US9187532B2 (en) | 2006-07-21 | 2015-11-17 | Novo Nordisk A/S | Glycosylation of peptides via O-linked glycosylation sequences |
| US8969532B2 (en) | 2006-10-03 | 2015-03-03 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5098193A (en) | 1994-03-29 |
| WO1994005332A2 (fr) | 1994-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2599503A3 (fr) | Conjugués de polymère d'interféron bêta-1A et leurs utilisations | |
| CA2064835A1 (fr) | Nouvelle composition complexe emulsifiee | |
| AU4488593A (en) | Low diol polyalkylene oxide biologically active proteinaceous substances | |
| AU6099694A (en) | Azlactone activated polyalkylene oxides | |
| AU6475394A (en) | Silanes with hydrophilic groups, their synthesis and use as surfactants in aqueous media | |
| EP1818342A3 (fr) | Antigènes à CLTA-8 de primates purifiés et réactifs correspondants | |
| NZ336961A (en) | Polymer blend comprising a polyester, a polyfunctional acid anhydride and a polyhydric alcohol | |
| AU587721B2 (en) | Large stub bottles and mated combination unit | |
| AU2755688A (en) | Aqueous dispersion of particulate water soluble polymers in polyethylene glycol | |
| AU8575991A (en) | Ultrahigh efficiency alkylene oxide catalysts having enhanced stability | |
| CA2323048A1 (fr) | Derives de poly(ethylene glycol) avec groupes reactifs proximaux | |
| IE890116L (en) | Conjugation of polymer to colony stimulating factor-1 | |
| EP0665994A4 (en) | Contactless power delivery system. | |
| ZA967712B (en) | Polyalkylene ethers as plasticizers and flow aids in poly (1,4-cyclohexanedimethylene terephthalate) resins | |
| CA2190373A1 (fr) | Souches de levure | |
| AU4660789A (en) | Polypeptide derivatives | |
| AU4216389A (en) | Red-shifted phthalocyanine and tetrabenztriazaporphyrin reagents | |
| EP0602845A3 (en) | Message dispatching in an event driven architecture. | |
| WO1989008673A3 (fr) | Polyesters hydrophiles modifies | |
| GR3034309T3 (en) | IFN--g(b) LIQUID FORMULATIONS | |
| AU4323589A (en) | Foldable and portable two-wheel motor vehicle | |
| AU8438998A (en) | Glycidyl ether aliphatic polyalcohols as coupling agents in anionic polymerization | |
| AU5444494A (en) | 1.8''pcmcia compatible drive having two or more disks | |
| ITRM930157A0 (it) | Diaframma per modulo di innesto e suo modulo di innesto, in particolare per autoveicoli. | |
| AU3729889A (en) | Branched hydroxy-terminated aliphatic polyethers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA JP |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: CA |